Trials / Completed
CompletedNCT04862247
Online Relapse Prevention Study
A Pilot Randomized Control Trial of a Relapse Prevention Online Exposure Protocol for Eating Disorders and Mechanisms of Change
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- University of Louisville · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect preliminary data on the feasibility and acceptability of the randomization of two relapse-prevention treatment conditions after discharge from intensive eating disorder (ED) treatment: an imaginal exposure therapy and a writing and thinking intervention. The second aim to test for (a) differences between the two treatments for the prevention of relapse and (b) preliminary change on clinical ED outcomes (e.g., ED symptoms, fears). The investigators further aim to examine the two treatments target fear extinction and if fear extinction is associated with ED outcomes. The investigators also plan to test if baseline differences in fear conditioning relate to change in ED outcomes across treatment.
Conditions
- Eating Disorders
- Anorexia Nervosa
- Bulimia Nervosa
- Anorexia Nervosa, Atypical
- Other Specified Feeding or Eating Disorder
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Imaginal Exposure Condition | Participants will be asked to think and write about an eating related fear or anxiety. Specifically, they will be asked to spend 20-30 minutes writing about a specific fear or anxiety they have, then another 20-35 minutes re-reading and imagining that what they have written is happening. |
| BEHAVIORAL | Writing and Thinking Condition | Participants will be asked to think and write about their eating disorder using specific prompts designed to help them process their eating disorder. Specifically, they will be asked to spend 20-30 minutes writing their eating disorder, then another 20-35 minutes re-reading what they wrote. |
Timeline
- Start date
- 2021-06-04
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2021-04-27
- Last updated
- 2025-03-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04862247. Inclusion in this directory is not an endorsement.